Fundly.ai raises $4M to expand pharma supply-chain platform
What's the deal? Mumbai-based Fundly.aiDealroom has a profile for this one. Try Dealroom →, a B2B pharma distribution platform, has raised $4 million in an early-stage round led by existing investors Accel and Multiply. Former RBL BankDealroom has a profile for this one. Try Dealroom → executive director Rajeev AhujaDealroom has a profile for this one. Try Dealroom → and a group of angel investors also joined, and the company raised a further $0.9 million in venture debt.
What's the endgame? Founded in 2021, FundlyDealroom has a profile for this one. Try Dealroom → started as a supply-chain finance platform for pharma companies. It has since expanded into three interconnected businesses: B2B commerce, transaction and settlement infrastructure, and embedded credit.
Where does the money go? The company plans to expand its digital commerce, payments, and credit offerings across India's pharma supply chain.
The signal: At $4 million, the round sits mid-pack among early-stage deals — a modest but telling bet on fintech built into India's fragmented pharma distribution network. Backing from repeat investors and a veteran banker points to confidence in Fundly's move from single-product lending toward a broader commerce-and-credit platform.
Read more: economictimes.indiatimes.com
Image credit: Generated with Gemini
